These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 33233403

  • 1. Generation of an Oncolytic Herpes Simplex Viral Vector Completely Retargeted to the GDNF Receptor GFRα1 for Specific Infection of Breast Cancer Cells.
    Hall BL, Leronni D, Miyagawa Y, Goins WF, Glorioso JC, Cohen JB.
    Int J Mol Sci; 2020 Nov 21; 21(22):. PubMed ID: 33233403
    [Abstract] [Full Text] [Related]

  • 2. A Strategy for Cultivation of Retargeted Oncolytic Herpes Simplex Viruses in Non-cancer Cells.
    Leoni V, Gatta V, Casiraghi C, Nicosia A, Petrovic B, Campadelli-Fiume G.
    J Virol; 2017 May 15; 91(10):. PubMed ID: 28250120
    [Abstract] [Full Text] [Related]

  • 3. Antibody Screening System Using a Herpes Simplex Virus (HSV)-Based Probe To Identify a Novel Target for Receptor-Retargeted Oncolytic HSVs.
    Ikeda H, Uchida H, Okubo Y, Shibata T, Sasaki Y, Suzuki T, Hamada-Uematsu M, Hamasaki R, Okuda K, Yamaguchi M, Kojima M, Tanaka M, Hamada H, Tahara H.
    J Virol; 2021 Apr 12; 95(9):. PubMed ID: 33627393
    [Abstract] [Full Text] [Related]

  • 4. Restriction of Replication of Oncolytic Herpes Simplex Virus with a Deletion of γ34.5 in Glioblastoma Stem-Like Cells.
    Peters C, Paget M, Tshilenge KT, Saha D, Antoszczyk S, Baars A, Frost T, Martuza RL, Wakimoto H, Rabkin SD.
    J Virol; 2018 Aug 01; 92(15):. PubMed ID: 29793956
    [Abstract] [Full Text] [Related]

  • 5. Development of an oncolytic HSV vector fully retargeted specifically to cellular EpCAM for virus entry and cell-to-cell spread.
    Shibata T, Uchida H, Shiroyama T, Okubo Y, Suzuki T, Ikeda H, Yamaguchi M, Miyagawa Y, Fukuhara T, Cohen JB, Glorioso JC, Watabe T, Hamada H, Tahara H.
    Gene Ther; 2016 Jun 01; 23(6):479-88. PubMed ID: 26905369
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Oncolytic Herpes Simplex Virus Vectors Fully Retargeted to Tumor- Associated Antigens.
    Uchida H, Hamada H, Nakano K, Kwon H, Tahara H, Cohen JB, Glorioso JC.
    Curr Cancer Drug Targets; 2018 Jun 01; 18(2):162-170. PubMed ID: 28176649
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Syncytial Mutations Do Not Impair the Specificity of Entry and Spread of a Glycoprotein D Receptor-Retargeted Herpes Simplex Virus.
    Okubo Y, Uchida H, Wakata A, Suzuki T, Shibata T, Ikeda H, Yamaguchi M, Cohen JB, Glorioso JC, Tagaya M, Hamada H, Tahara H.
    J Virol; 2016 Dec 15; 90(24):11096-11105. PubMed ID: 27707922
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Inhibition of human tumor growth in mice by an oncolytic herpes simplex virus designed to target solely HER-2-positive cells.
    Menotti L, Nicoletti G, Gatta V, Croci S, Landuzzi L, De Giovanni C, Nanni P, Lollini PL, Campadelli-Fiume G.
    Proc Natl Acad Sci U S A; 2009 Jun 02; 106(22):9039-44. PubMed ID: 19458262
    [Abstract] [Full Text] [Related]

  • 13. Effective treatment of an orthotopic xenograft model of human glioblastoma using an EGFR-retargeted oncolytic herpes simplex virus.
    Uchida H, Marzulli M, Nakano K, Goins WF, Chan J, Hong CS, Mazzacurati L, Yoo JY, Haseley A, Nakashima H, Baek H, Kwon H, Kumagai I, Kuroki M, Kaur B, Chiocca EA, Grandi P, Cohen JB, Glorioso JC.
    Mol Ther; 2013 Mar 02; 21(3):561-9. PubMed ID: 23070115
    [Abstract] [Full Text] [Related]

  • 14. Assessment of oncolytic HSV efficacy following increased entry-receptor expression in malignant peripheral nerve sheath tumor cell lines.
    Jackson JD, McMorris AM, Roth JC, Coleman JM, Whitley RJ, Gillespie GY, Carroll SL, Markert JM, Cassady KA.
    Gene Ther; 2014 Nov 02; 21(11):984-90. PubMed ID: 25119379
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Oncolytic herpes simplex virus treatment of metastatic breast cancer.
    Wang J, Hu P, Zeng M, Rabkin SD, Liu R.
    Int J Oncol; 2012 Mar 02; 40(3):757-63. PubMed ID: 22108767
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.